World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
17126
World Ranking
7021
National Ranking
3232

Chemistry

D-Index
67
Citations
14036
World Ranking
7020
National Ranking
2087

Wei Li publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Wei Li sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 298 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Wei Li D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Wei Li sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 67 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Wei Li is affiliated with the University of Tennessee Health Science Center in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad areas, Wei Li has contributed extensively to subfields such as Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research, and Organic Chemistry.

Their publication record includes a focus on topics related to cancer research and treatment. Key areas of study encompass HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer Therapeutics and Mechanisms, MicroRNA in Disease Regulation, and Monoclonal and Polyclonal Antibodies Research.

Wei Li's most frequent co-authors include:

  • Binghe Xu (24 joint publications)
  • Duane D. Miller (23 joint publications)
  • Zhongsheng Tong (21 joint publications)
  • Yongmei Yin (20 joint publications)
  • Hao Chen (16 joint publications)

Thevenues where Wei Li has published most frequently are:

  • Journal of Clinical Oncology (20 publications)
  • Frontiers in Oncology (16 publications)
  • Cancer Research (14 publications)
  • Research Square (13 publications)
  • SSRN Electronic Journal (11 publications)

Among the recent papers authored or co-authored by Wei Li are:

  • "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer," 2022, New England Journal of Medicine
  • "Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial," 2022, The Lancet
  • "Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial," 2021, The Lancet Oncology
  • "Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development," 2020, Current Medicinal Chemistry
  • "Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer," 2020, Journal of Clinical Investigation

Best Publications

  • HIF-1α pathway: role, regulation and intervention for cancer therapy

    Georgina N. Masoud;Wei Li

  • An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site

    Yan Lu;Jianjun Chen;Min Xiao;Wei Li

  • Steroidogenesis in the skin: Implications for local immune functions

    Andrzej Slominski;Blazej Zbytek;Georgios Nikolakis;Pulak R. Manna

  • The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.

    Najah Albadari;Shanshan Deng;Wei Li

  • Novel activities of CYP11A1 and their potential physiological significance

    Andrzej T. Slominski;Wei Li;Tae Kang Kim;Igor Semak

  • In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1

    Andrzej T. Slominski;Tae Kang Kim;Haleem Z. Shehabi;Igor Semak

  • RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D

    Andrzej T. Slominski;Tae Kang Kim;Yukimasa Takeda;Zorica Janjetovic

  • Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging.

    Kheireddine El-Boubbou;David C. Zhu;Chrysoula Vasileiou;Babak Borhan

  • Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6.

    Arduino A. Mangoni;Catherine Guillou;Jean Jacques Vanden Eynde;Christopher Hulme

  • Dynamic split tensile test of Flattened Brazilian Disc of rock with SHPB setup

    Q.Z. Wang;W. Li;H.P. Xie

  • Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.

    Yan Lu;Chien-Ming Li;Zhao Wang;Charles R. Ross

  • Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.

    Hao Chen;Zongtao Lin;Kinsie E Arnst;Duane D Miller

  • Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland

    Andrzej T. Slominski;Andrzej T. Slominski;Tae Kang Kim;Wei Li;Arnold Postlethwaite;Arnold Postlethwaite

  • Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development

    Hanxuan Li;Zhousheng Xiao;L. Darryl Quarles;Wei Li

  • Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages.

    Medha Kamat;Kheireddine El-Boubbou;David C. Zhu;Teri Lansdell

  • The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism

    Andrzej Slominski;Igor Semak;Jordan Zjawiony;Jacobo Wortsman

  • Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells

    Tae-Kang Kim;Konrad Kleszczyński;Zorica Janjetovic;Trevor Sweatman

  • The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.

    Andrzej T. Slominski;Tae Kang Kim;Wei Li;Ae-Kyung Yi

  • Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.

    Andrzej T. Slominski;Zorica Janjetovic;Brian E. Fuller;Michal A. Zmijewski

  • Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ

    Andrzej T. Slominski;Andrzej T. Slominski;Tae Kang Kim;Judith V. Hobrath;Allen S.W. Oak

  • The role of vitamin D in cancer prevention

    Rachel A. Ness;Duane D. Miller;Wei Li

Frequent Co-Authors

Duane D. Miller
Duane D. Miller University of Tennessee Health Science Center
Andrzej Slominski
Andrzej Slominski University of Alabama at Birmingham
Robert C. Tuckey
Robert C. Tuckey University of Western Australia
James T. Dalton
James T. Dalton St. Jude Children's Research Hospital
Arnold E. Postlethwaite
Arnold E. Postlethwaite University of Tennessee Health Science Center
Jordan K. Zjawiony
Jordan K. Zjawiony University of Mississippi
Subhash C. Chauhan
Subhash C. Chauhan The University of Texas Rio Grande Valley
Meena Jaggi
Meena Jaggi University of Tennessee Health Science Center
Xuedong Zhou
Xuedong Zhou Sichuan University
Ram I. Mahato
Ram I. Mahato University of Nebraska Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, exploring related online degrees can open diverse career pathways beyond traditional laboratory roles. For example, those drawn to the legal side of science might consider degrees for paralegals, which offer a foundation in legal procedures that can complement a chemistry background.

Pharmaceutical fields are also a natural fit. Becoming a pharmaceutical sales representative offers a dynamic career option where understanding drug composition is crucial. To learn more about earnings and progression in this area, see our guide on drug rep salary.

If you are passionate about patient care and advanced science, pursuing a career as a pharmacist requires significant education. Details on the necessary training can be found at how much schooling to be a pharmacist.

For those fascinated by forensic applications of chemistry, becoming an autopsy technician is a specialized path. Understanding the educational demands and job outlook is key, and useful information is available at autopsy technician school.

Best Scientists Citing Wei Li

Trending Scientists

Recently Published Articles